“☃【텔레 GD684】 동종업계1위❤️ 작대업체 작업대출가능한곳 연체자작대❤️☃”的搜索结果，显示 41-50 项，共有 13604 项

1. 患者就诊及探视者最新信息：罗切斯特院区- 妙佑医疗国际

   Patient appointment & visitor updates: Rochester · In this section · Before your clinic appointments · Attending your in-person clinic appointments.

2. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

3. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

4. 食管癌- 医生与科室- 妙佑医疗国际

   测试使用已知对食管癌有效的药物的新方法，并研究化疗和放射疗法的最佳组合; 改进食管切除术的手术技巧. 癌症研究 ...

5. 放射科- 临床试验- 妙佑医疗国际

   The purpose of this study is to examine the ability of PCD-CT to (1) display subtle fractures of the wrist using the system's increased spatial resolution ...

6. 血液科- 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

7. 血液科- 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

8. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

9. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...